Cardiff Lexington Corporation (CDIX)
OTCMKTS · Delayed Price · Currency is USD
1.500
-0.500 (-25.00%)
At close: Aug 12, 2025
Cardiff Lexington Market Cap
Cardiff Lexington has a market cap or net worth of $29.52 million as of August 29, 2025. Its market cap has increased by 88,777.48% in one year.
Market Cap
29.52M
Enterprise Value
97.73M
Revenue
10.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.50
Market Cap Chart
Since July 19, 2004, Cardiff Lexington's market cap has increased from 3.75M to 29.52M, an increase of 688.27%. That is a compound annual growth rate of 10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 29.52M | 8,078.73% |
| Dec 29, 2023 | 360.98K | 40.97% |
| Dec 29, 2022 | 256.06K | 10.12% |
| Dec 31, 2021 | 232.53K | 142.94% |
| Dec 31, 2020 | 95.71K | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 840.66M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 654.71M |
| Elite Pharmaceuticals | 586.30M |
| CytoDyn | 397.64M |
| American Oncology Network | 369.59M |
| Northwest Biotherapeutics | 357.21M |